Vanguard Group Inc Bio Rad Laboratories, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,919,808 shares of BIO stock, worth $532 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,919,808
Previous 1,907,640
0.64%
Holding current value
$532 Million
Previous $638 Million
1.19%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding BIO
# of Institutions
480Shares Held
19.6MCall Options Held
15.5KPut Options Held
12.3K-
Black Rock Inc. New York, NY1.55MShares$430 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$289 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$271 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$207 Million0.06% of portfolio
-
Van Eck Associates Corp723KShares$201 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.83B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...